Forma Therapeutics, Inc.

This study is testing a daily oral medication called etavopivat in adolescents with sickle cell disease. Researchers want to understand how safe the drug is, how it moves through the body, and whether it helps reduce complications like pain crises. About 50 participants will take…

This study is testing a new daily pill called etavopivat to see if it can lower the high risk of stroke in children with sickle cell disease. It will involve about 27 children aged 12-16 who have fast blood flow in their brain arteries, a key warning sign for stroke. The main goa…